Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Summary

Heartflow (Nasdaq: HTFL), a leader in AI-powered coronary artery disease technology, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's management will engage in a fireside chat scheduled for September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

Investors can access both live and archived versions of the presentation through Heartflow's Investor Relations website at ir.heartflow.com.

News Market Reaction – HTFL

-7.54%

35 alerts

-7.54% Session close to close

+10.8% Peak Tracked

-3.9% Trough Tracked

$2.94B Market Cap

0.3x Rel. Volume

In the Aug 28 session, HTFL declined 7.54%, reflecting a notable negative market reaction. Argus tracked a peak move of +10.8% during that session. Argus tracked a trough of -3.9% from its starting point during tracking. Our momentum scanner triggered 35 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley 23^rd Annual Global Healthcare Conference. The fireside chat will take place on Wednesday, September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com.

About Heartflow, Inc.
Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFR_CT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. Heartflow has helped clinicians manage over 400,000 patients worldwide. Discover how we’re shaping the future of cardiovascular care at www.heartflow.com.

Investor Contact
Nick Laudico
nlaudico@heartflow.com

Media Contact
Elliot Levy
elevy@heartflow.com

FAQ

When is Heartflow (HTFL) presenting at the Morgan Stanley Healthcare Conference 2025?

Heartflow will present on September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

Where can I watch Heartflow's Morgan Stanley Conference presentation?

The presentation will be available both live and archived on Heartflow's Investor Relations website at ir.heartflow.com.

What is Heartflow's (HTFL) main business focus?

Heartflow is a leader in AI technology for coronary artery disease (CAD).

What type of presentation will Heartflow give at the Morgan Stanley Healthcare Conference?

Heartflow's management will participate in a fireside chat format presentation.